Dehua Lu

765 total citations
29 papers, 575 citations indexed

About

Dehua Lu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dehua Lu has authored 29 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Dehua Lu's work include Nanoplatforms for cancer theranostics (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Research and Treatments (3 papers). Dehua Lu is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Research and Treatments (3 papers). Dehua Lu collaborates with scholars based in China, Ethiopia and South Korea. Dehua Lu's co-authors include Zhaofei Liu, Fucheng Yin, Shang Li, Lingyi Kong, Xiaobing Wang, Xingchen Liu, Lailiang Qu, Heng Luo, Yang Zhao and Xinye Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Cancer Research.

In The Last Decade

Dehua Lu

27 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dehua Lu China 16 311 165 109 86 67 29 575
Xiaoyong Dai China 15 350 1.1× 116 0.7× 62 0.6× 99 1.2× 42 0.6× 56 620
Yanfang Wang China 17 174 0.6× 176 1.1× 98 0.9× 91 1.1× 23 0.3× 31 577
Jihye Ryu South Korea 17 312 1.0× 149 0.9× 77 0.7× 45 0.5× 48 0.7× 38 592
Vincent Guerlavais United States 11 397 1.3× 214 1.3× 66 0.6× 40 0.5× 102 1.5× 22 650
Sireesha V. Garimella United States 6 437 1.4× 250 1.5× 51 0.5× 68 0.8× 64 1.0× 11 723
Sabina Y. van der Zanden Netherlands 9 295 0.9× 169 1.0× 72 0.7× 74 0.9× 57 0.9× 18 612
Jingbo Yang China 15 310 1.0× 70 0.4× 68 0.6× 101 1.2× 44 0.7× 28 605
Qi Huang China 16 287 0.9× 124 0.8× 67 0.6× 35 0.4× 62 0.9× 47 572
Yunjiang Zhou China 15 420 1.4× 145 0.9× 106 1.0× 43 0.5× 48 0.7× 22 640
Ariadna Sarrats Spain 11 493 1.6× 113 0.7× 151 1.4× 48 0.6× 81 1.2× 14 679

Countries citing papers authored by Dehua Lu

Since Specialization
Citations

This map shows the geographic impact of Dehua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dehua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dehua Lu more than expected).

Fields of papers citing papers by Dehua Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dehua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dehua Lu. The network helps show where Dehua Lu may publish in the future.

Co-authorship network of co-authors of Dehua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Dehua Lu. A scholar is included among the top collaborators of Dehua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dehua Lu. Dehua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyu, Weiping, et al.. (2026). Xanthine oxidase inhibitors for gout: Applications and novel drug development. European Journal of Medicinal Chemistry. 307. 118619–118619.
2.
Zhao, Yanping, Dehua Lu, Yanming Chen, et al.. (2025). Development of Potent SHP2 Allosteric Inhibitors: Design, Synthesis, and Evaluation with Antitumor Effects. Journal of Medicinal Chemistry. 68(5). 5238–5256. 1 indexed citations
3.
Yin, Minghao, Jinfeng Wang, Xiaopeng Zhu, et al.. (2025). Cold Plasma-Activated Medium Reverses Chemoresistance in Colorectal Cancer via ROS-Mediated Suppression of ABC Transporters and Redox Homeostasis Disruption. IEEE Transactions on Radiation and Plasma Medical Sciences. 10(2). 299–316.
4.
Li, Chao, Hongye Wang, Zixi Yan, et al.. (2024). C—F Bond Insertion into Indoles with CHBr2F: An Efficient Method to Synthesize Fluorinated Quinolines and Quinolones. Chinese Journal of Chemistry. 42(10). 1128–1132. 21 indexed citations
5.
Lu, Dehua, Wenhua Li, Ying Li, et al.. (2024). STING Agonist Delivered by Neutrophil Membrane-Coated Gold Nanoparticles Exerts Synergistic Tumor Inhibition with Radiotherapy. ACS Applied Materials & Interfaces. 16(40). 53474–53488. 12 indexed citations
6.
Zheng, Yuanyuan, Wei Yang, Feng Jin, et al.. (2024). Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics. Translational Oncology. 45. 101926–101926. 1 indexed citations
7.
Wang, Cheng, Heng Luo, Xinye Chen, et al.. (2023). Discovery of dual PARP and CDK6 inhibitors for triple-negative breast cancer with wild-type BRCA. Bioorganic Chemistry. 139. 106683–106683. 11 indexed citations
8.
Chen, Xinye, Cheng Wang, Dehua Lu, et al.. (2023). Design, synthesis and mechanism studies of dual EZH2/BRD4 inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry. 91. 117386–117386. 6 indexed citations
9.
10.
Wang, Cheng, Xinye Chen, Xingchen Liu, et al.. (2022). Discovery of precision targeting EZH2 degraders for triple-negative breast cancer. European Journal of Medicinal Chemistry. 238. 114462–114462. 38 indexed citations
11.
Lu, Dehua, Lailiang Qu, Cheng Wang, et al.. (2022). Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy. Bioorganic Chemistry. 120. 105604–105604. 16 indexed citations
12.
Zhao, Yang, Ting Zhang, Yanpu Wang, et al.. (2021). ICAM-1 orchestrates the abscopal effect of tumor radiotherapy. Proceedings of the National Academy of Sciences. 118(14). 34 indexed citations
13.
Lu, Dehua, Yanpu Wang, Ting Zhang, et al.. (2021). Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy. Journal of Nanobiotechnology. 19(1). 175–175. 18 indexed citations
14.
Qu, Lailiang, Cheng Wang, Heng Luo, et al.. (2021). Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer’s disease. European Journal of Medicinal Chemistry. 219. 113441–113441. 33 indexed citations
15.
Wang, Yanpu, Dehua Lu, Xiaoxia Xu, et al.. (2020). Clinical Translation of a68Ga-Labeled Integrin αvβ6–Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer. Journal of Nuclear Medicine. 61(10). 1461–1467. 42 indexed citations
16.
Wang, Yanpu, Chenran Zhang, Jianhao Lai, et al.. (2020). Noninvasive PET tracking of post-transplant gut microbiota in living mice. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 991–1002. 16 indexed citations
17.
Qu, Lailiang, Cheng Wang, Peng Wan, et al.. (2020). Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2. European Journal of Medicinal Chemistry. 210. 112965–112965. 26 indexed citations
18.
Zhao, Yang, Chenran Zhang, Liquan Gao, et al.. (2017). Chemotherapy-Induced Macrophage Infiltration into Tumors Enhances Nanographene-Based Photodynamic Therapy. Cancer Research. 77(21). 6021–6032. 21 indexed citations
19.
Lai, Jianhao, Dehua Lu, Chenran Zhang, et al.. (2017). Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy. Biomaterials. 158. 1–9. 17 indexed citations
20.
Zhang, Chenran, Xinhe Yu, Liquan Gao, et al.. (2017). Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis. Theranostics. 7(17). 4276–4288. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyong Dai Breakdown of academic impact, for papers by Yanfang Wang Breakdown of academic impact, for papers by Jihye Ryu Breakdown of academic impact, for papers by Vincent Guerlavais Breakdown of academic impact, for papers by Sireesha V. Garimella Breakdown of academic impact, for papers by Sabina Y. van der Zanden Breakdown of academic impact, for papers by Jingbo Yang Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Yunjiang Zhou Breakdown of academic impact, for papers by Ariadna Sarrats
Rankless by CCL
2026